STOCK TITAN

Ametek, Inc. - AME STOCK NEWS

Welcome to our dedicated page for Ametek news (Ticker: AME), a resource for investors and traders seeking the latest updates and insights on Ametek stock.

AMETEK, Inc. (NYSE: AME) is a leading global provider of industrial technology solutions, with annual sales of over $6 billion. The company operates through two primary segments: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG). EIG designs and manufactures advanced instruments for the process, aerospace, power, and industrial markets. EMG focuses on highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects.

With a workforce of approximately 15,000 employees, AMETEK has a strong presence worldwide, operating over 120 manufacturing locations and maintaining 100 sales and service locations in more than 30 countries. The company is committed to four key growth strategies: Operational Excellence, Strategic Acquisitions & Alliances, Global & Market Expansion, and New Product Development. Through these strategies, AMETEK aims to double its size and profitability within the next five years.

Recent achievements include the acquisition of Paragon Medical for approximately $1.9 billion, further enhancing AMETEK's capabilities in the medical technology sector. The company also declared a regular quarterly dividend of $0.28 per share, reflecting its strong financial performance and commitment to delivering shareholder value.

Founded in 1930 and listed on the NYSE for over 90 years, AMETEK is a component of the S&P 500. The company's disciplined focus on cash generation and capital deployment supports its long-term objective of achieving double-digit percentage growth in earnings per share and superior returns on total capital. For more information, visit www.ametek.com.

Rhea-AI Summary

On November 5, 2021, AMETEK, Inc. (NYSE: AME) announced the election of Nino DiPietro as Vice President, Audit Services. DiPietro, previously Director of Audit Services, brings extensive financial and operational experience in the industrial sector. His career at AMETEK began in the Financial Management Development Program and includes significant roles in finance at FlexLink Systems and CRC Industries. AMETEK aims for double-digit earnings per share growth and reported annualized sales of $5.5 billion, maintaining its position as an S&P 500 component.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
none
-
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) has appointed Emanuela Speranza as the new Chief Commercial Officer, effective January 1, 2022. In this role, she will focus on driving organic sales growth and overseeing global marketing communications while enhancing digitalization efforts. Speranza has been with AMETEK since 2014, previously serving as Vice President and General Manager in Europe. AMETEK, a leading global manufacturer with annual sales of $5.5 billion, aims for double-digit earnings per share growth through its strategic growth model.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
none
-
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) announced the appointment of Dave Hermance as President of the Electromechanical Group, effective January 1, 2022. Hermance, currently Vice President and General Manager of the Measurement, Communications and Testing Division, succeeds Tim Jones, who retires after 42 years. CEO David A. Zapico praised Hermance for his contributions to AMETEK's growth, especially in integrating acquisitions. AMETEK reported annual sales of $5.5 billion and aims for double-digit earnings growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
none
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) reported record financial results for Q3 2021, with sales of $1.44 billion, marking a 28% increase from Q3 2020. Operating income rose by 25% to $337.6 million, and adjusted earnings per diluted share reached a record $1.26, reflecting a 25% increase year-over-year. The company has a robust backlog of $2.6 billion and is raising its full-year sales and earnings guidance, projecting sales growth in the low 20% range and adjusted earnings per share of $4.76 to $4.78. AMETEK's Electronic Instruments Group and Electromechanical Group both experienced significant growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.33%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
none
-
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) will release its third quarter 2021 earnings on November 2, 2021, before market open. A webcast of the investor conference call will follow at 8:30 AM ET on the same day, accessible via the company’s website. AMETEK reported over $4.5 billion in annual sales for 2020 and aims for double-digit growth in earnings per share throughout the business cycle, while also focusing on capital deployment and cash generation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.04%
Tags
Rhea-AI Summary

AMETEK announced the election of Sheldon Thorpe as Vice President of Human Resources on August 6, 2021. Thorpe, who joined the company in 2016, will oversee talent acquisition, leadership development, diversity initiatives, and U.S. payroll systems. CEO David A. Zapico expressed confidence in Thorpe's expertise and commitment to enhancing AMETEK's performance culture. The company, a global leader in electronic instruments and devices, reported annual sales of $5.5 billion and aims for double-digit earnings per share growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
none
-
News
Rhea-AI Summary

AMETEK, Inc. has declared a quarterly dividend of $0.20 per share for the third quarter ending September 30, 2021. Shareholders of record as of September 14, 2021 will receive the dividend on September 30, 2021. The company, a leader in electronic instruments and electromechanical devices, reported annualized sales of approximately $5.5 billion. AMETEK aims for double-digit growth in earnings per share and emphasizes cash generation and capital deployment strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.06%
Tags
dividends
-
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) reported record financial results for Q2 2021, achieving sales of $1.39 billion, a 37% increase year-over-year. Organic sales growth stood at 25%, with operating income reaching $316.6 million, up 39%. Adjusted earnings per diluted share were a record $1.15, reflecting a 37% rise from last year. Both Electronic Instruments Group (EIG) and Electromechanical Group (EMG) showed strong performance, with sales increases of 44% and 24%, respectively. AMETEK has raised its 2021 sales guidance to an estimated increase of approximately 20%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.39%
Tags
none
Rhea-AI Summary

AMETEK, Inc. (NYSE: AME) is set to release its second quarter 2021 earnings on August 3, 2021, prior to market opening. The company will also host a webcast of its investor conference call at 8:30 AM ET on the same day. AMETEK reported over $4.5 billion in annual sales for 2020 and aims for double-digit growth in earnings per share. The company employs a strategic growth model focusing on operational excellence, product development, global expansion, and acquisitions, reinforcing its commitment to capital generation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags

FAQ

What is the current stock price of Ametek (AME)?

The current stock price of Ametek (AME) is $183.36 as of December 20, 2024.

What is the market cap of Ametek (AME)?

The market cap of Ametek (AME) is approximately 42.0B.

What does AMETEK, Inc. do?

AMETEK, Inc. is a global provider of industrial technology solutions, focusing on advanced instruments and engineered automation solutions for various markets.

What are the key business segments of AMETEK?

AMETEK operates through two main segments: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG).

How many employees does AMETEK have?

AMETEK has approximately 15,000 employees worldwide.

What are AMETEK's growth strategies?

AMETEK's growth strategies include Operational Excellence, Strategic Acquisitions & Alliances, Global & Market Expansion, and New Product Development.

What recent acquisitions has AMETEK made?

Recently, AMETEK acquired Paragon Medical for approximately $1.9 billion, enhancing its capabilities in the medical technology sector.

What is AMETEK's annual sales figure?

AMETEK's annual sales exceed $6 billion.

When was AMETEK founded?

AMETEK was founded in 1930.

Is AMETEK listed on any stock exchange?

Yes, AMETEK is listed on the New York Stock Exchange (NYSE) under the symbol AME.

What is AMETEK's dividend policy?

AMETEK declared a regular quarterly dividend of $0.28 per share, reflecting its strong financial performance.

Where can I find more information about AMETEK?

For more information, visit AMETEK's official website at www.ametek.com.

Ametek, Inc.

NYSE:AME

AME Rankings

AME Stock Data

41.96B
230.21M
0.41%
88.2%
1.15%
Specialty Industrial Machinery
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
BERWYN